Literature DB >> 28329155

Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.

Mark-Jan Ploegstra1, Jody G M Brokelman1, Jolien W Roos-Hesselink2, Johannes M Douwes1, Lenny M van Osch-Gevers3, Elke S Hoendermis4, Annemien E van den Bosch2, Maarten Witsenburg2,3, Beatrijs Bartelds1, Hans L Hillege5, Rolf M F Berger1.   

Abstract

Aims: Prognosis in children with pulmonary vascular disease (PVD) is closely linked to right ventricular (RV) failure due to increased RV-afterload. Pulmonary arterial (PA) stiffening is known to occur early in the course of PVD and constitutes a main component of RV-afterload. This study aimed to evaluate the clinical value of PA-stiffness in children with PVD by determining its association with advanced pulmonary arterial hypertension (PAH) and mortality at long-term follow-up. Methods and results: Forty-one children with various stages of arterial PVD, defined as mean PA-pressure  ≥20 mmHg and/or pulmonary-to-systemic flow-ratio  ≥1.2, and mean pulmonary capillary wedge pressure  <15 mmHg, underwent cardiac catheterization with intravascular ultrasound (IVUS) imaging between 1994 and 1997 with follow-up until 2015. PA-stiffness indices evaluated were PA-area-compliance (PA-compliance) and PA-area-distensibility (PA-distensibility). During follow-up, advanced PAH was determined by echocardiography and cardiac catheterization. During a median follow-up of 19 years, in 31 (76%) patients PVD had reversed and 10 (24%) had advanced PAH. Six (15%) died due to PVD. In addition to conventional haemodynamics, PA-compliance and PA-distensibility were associated with advanced PAH at long-term follow-up (adjusted OR [95% CI] 0.56 [0.37-0.85] and 0.52 [0.31-0.86]), and mortality (adjusted HR [95% CI] 0.60 [0.41-0.87] and 0.67 [0.49-0.90]). Also in a subgroup of patients with favourable haemodynamics, baseline PA-compliance and PA-distensibility were lower in patients with advanced PAH at follow-up (P  =  0.002 /P  =  0.030).
Conclusion: In children with PVD, PA-stiffness indices assessed by IVUS predict advanced PAH and mortality at long term follow-up. Especially in patients with favourable haemodynamics, assessment of intrinsic PA-stiffness may enhance the prognostication of disease progression and survival. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  congenital heart disease; outcome; paediatrics; pulmonary arterial hypertension; pulmonary vascular disease; stiffness

Mesh:

Year:  2018        PMID: 28329155     DOI: 10.1093/ehjci/jex015

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  9 in total

1.  Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.

Authors:  Richard M Friesen; Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Kendall S Hunter; Uyen Truong
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

2.  Pulmonary lung Doppler signals: normative data in a pediatric population compared with adults.

Authors:  Danielle S Burstein; Rachel K Hopper; Elisa K McCarthy; Keeley Hall; Rachel Schatzberger; Yoram Palti; Jeffrey A Feinstein
Journal:  J Clin Monit Comput       Date:  2019-01-19       Impact factor: 2.502

Review 3.  The Mechanobiology of Vascular Remodeling in the Aging Lung.

Authors:  Paul B Dieffenbach; Aja Aravamudhan; Laura E Fredenburgh; Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2021-09-13

4.  Inverse modeling framework for characterizing patient-specific microstructural changes in the pulmonary arteries.

Authors:  Reza Pourmodheji; Zhenxiang Jiang; Christopher Tossas-Betancourt; C Alberto Figueroa; Seungik Baek; Lik-Chuan Lee
Journal:  J Mech Behav Biomed Mater       Date:  2021-03-27

Review 5.  Mechanobiological Feedback in Pulmonary Vascular Disease.

Authors:  Paul B Dieffenbach; Marcy Maracle; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  Front Physiol       Date:  2018-07-25       Impact factor: 4.566

6.  Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.

Authors:  Erika B Rosenzweig; Steven H Abman; Ian Adatia; Maurice Beghetti; Damien Bonnet; Sheila Haworth; D Dunbar Ivy; Rolf M F Berger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

7.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

Review 8.  Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension.

Authors:  Wei Sun; Stephen Y Chan
Journal:  Front Med (Lausanne)       Date:  2018-07-18

9.  Long-Term Effect of a Vaccine Targeting Endothelin-1 Receptor Type A in Pulmonary Arterial Hypertension.

Authors:  Yong Dai; Zhihua Qiu; Wenrui Ma; Chang Li; Xiao Chen; Xiaoxiao Song; Zeyang Bai; Dingyang Shi; Jiayu Zheng; Guangwei Pan; Yuhua Liao; Mengyang Liao; Zihua Zhou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.